PS -- it correct that "citizens of most other countries get [Truvada] for a small fraction of that price" — $1600 a month? As far as I can tell, our remarkably flawed health care titans have—shockingly—done a better job getting Prep to people affordably than anywhere in Europe.
The @nytimes editorial board weighs in. And WOW. I remember when they wrote an editorial against the price of AZT just a few weeks before ACT UP shut-down trading on the NY Stock Exchange. This feels like 1989 all over again. @PrEP4AllNow @GileadScienceshttps://nyti.ms/30h7Ppy
-
-
-
Australia, England and Holland are reaching better levels of use vs need. All got much later starts (much later regulatory approvals)
- Näytä vastaukset
Uusi keskustelu -
-
-
Silence STILL = Death.
Kiitos. Käytämme tätä aikajanasi parantamiseen. KumoaKumoa
-
Lataaminen näyttää kestävän hetken.
Twitter saattaa olla ruuhkautunut tai ongelma on muuten hetkellinen. Yritä uudelleen tai käy Twitterin tilasivulla saadaksesi lisätietoja.